TG Therapeutics, Inc. (TGTX): Price and Financial Metrics
TG Therapeutics, Inc. (TGTX)
Today's Latest Price: $26.07 USD
Updated Oct 26 8:27pm
Add TGTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
TGTX Stock Summary
- Tg Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 8.68% of US listed stocks.
- Of note is the ratio of Tg Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 9.61% of US stocks have a lower such ratio.
- With a price/sales ratio of 22,688.54, Tg Therapeutics Inc has a higher such ratio than 99.95% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Tg Therapeutics Inc, a group of peers worth examining would be NK, CYAD, TRVN, ATHX, and PSTI.
- TGTX's SEC filings can be seen here. And to visit Tg Therapeutics Inc's official web site, go to www.tgtherapeutics.com.
TGTX Stock Price Chart Interactive Chart >
TGTX Price/Volume Stats
| Current price | $26.07 | 52-week high | $31.97 |
| Prev. close | $27.00 | 52-week low | $5.90 |
| Day low | $25.37 | Volume | 1,978,700 |
| Day high | $27.00 | Avg. volume | 2,015,029 |
| 50-day MA | $26.22 | Dividend yield | N/A |
| 200-day MA | $18.53 | Market Cap | 3.30B |
TG Therapeutics, Inc. (TGTX) Company Bio
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company was founded in 1993 and is based in New York, New York.
Loading social stream, please wait...